701 - 710 of 6295 Results
Title
Year
-
OPENTitle: Addressing the Challenges of Clinical Research for Freezing of Gait in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 2Start Page: 264End Page: 267Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28837Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8840955Citation Count: 23
- Thalamic Dorsomedial Nucleus Free Water Correlates with Cognitive Decline in Parkinson's Disease2021OPENTitle: Thalamic Dorsomedial Nucleus Free Water Correlates with Cognitive Decline in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 3Start Page: 490End Page: 501Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28886Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8940677Citation Count: 14
- Comparison of Transcranial Sonography and [18F]‐Fluorodopa PET Imaging in GBA1 Mutation Carriers2021OPENTitle: Comparison of Transcranial Sonography and [18F]‐Fluorodopa PET Imaging in GBA1 Mutation CarriersJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 3Start Page: 629End Page: 634Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28852Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8940604Citation Count: 7
- Concomitant Medication Usage with Levodopa‐Carbidopa Intestinal Gel: Results from the COSMOS Study2021OPENTitle: Concomitant Medication Usage with Levodopa‐Carbidopa Intestinal Gel: Results from the COSMOS StudyJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 8Start Page: 1853End Page: 1862Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.28596Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28596Citation Count: 38
- Parkinsonism as a Sequela of SARS‐CoV‐2 Infection: Pure Hypoxic Injury or Additional COVID‐19‐Related Response?2021OPENTitle: Parkinsonism as a Sequela of SARS‐CoV‐2 Infection: Pure Hypoxic Injury or Additional COVID‐19‐Related Response?Journal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 7Start Page: 1483End Page: 1484Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28656Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28656Citation Count: 23
- Non‐Motor Fluctuations in Parkinson's Disease: Validation of the Non‐Motor Fluctuation Assessment Questionnaire2021OPENTitle: Non‐Motor Fluctuations in Parkinson's Disease: Validation of the Non‐Motor Fluctuation Assessment QuestionnaireJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 6Start Page: 1392End Page: 1400Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28507Best OA location URL: https://hdl.handle.net/2027.42/168292Citation Count: 37
- Glia Imaging Differentiates Multiple System Atrophy from Parkinson's Disease: A Positron Emission Tomography Study with [11C]PBR28 and Machine Learning Analysis2021OPENTitle: Glia Imaging Differentiates Multiple System Atrophy from Parkinson's Disease: A Positron Emission Tomography Study with [11C]PBR28 and Machine Learning AnalysisJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 1Start Page: 119End Page: 129Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.28814Best OA location URL: https://kclpure.kcl.ac.uk/portal/en/publications/dc04516a-d43f-4a65-914b-0c5d09b9e5d8Citation Count: 25
-
OPENTitle: Fluoxetine for the Symptomatic Treatment of Multiple System Atrophy: The MSA‐FLUO TrialJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 7Start Page: 1704End Page: 1711Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28569Best OA location URL: https://hal.science/hal-03190779Citation Count: 22
- Polyglutamine‐Expanded Ataxin‐3: A Target Engagement Marker for Spinocerebellar Ataxia Type 3 in Peripheral Blood2021OPENTitle: Polyglutamine‐Expanded Ataxin‐3: A Target Engagement Marker for Spinocerebellar Ataxia Type 3 in Peripheral BloodJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 11Start Page: 2675End Page: 2681Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/mds.28749Best OA location URL: https://doi.org/10.1002/mds.28749Citation Count: 31
-
OPENTitle: Parkinson's Disease and COVID‐19: Do We Need to Be More Patient?Journal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 2Start Page: 277End Page: 277Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28469Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28469Citation Count: 12